Triple Negative Breast Cancer, "I Won't Back Down!": The Anne M. Wolf Fund For Triple Negative Breast Cancer Research

What is TNBC

WHAT IS TRIPLE NEGATIVE BREAST CANCER?

Just in recent years, Triple Negative Breast Cancer (TNBC) has sparked interest in the news where instead of calling the tumor as ER-negative, PR-negative, and HER2-negative; researchers began using the shorthand term, "Triple Negative," dubbed the "new type" of breast cancer. Being Triple Negative, you don't have a targeted therapy and your only treatment option is chemotherapy.

Triple Negative Breast Cancer is seen in about 15% of all breast cancers. TNBC is a very aggressive cancer that tends to strike younger women, pre-menopause, especially among African-American women and women who have BRCA1 mutations. The tumor tends to be fast growing and is less likely to show up on an annual mammogram. TNBC is more likely to metastasis early on; has a high rate of recurrence in the first 2-3 years from diagnosis and has a poorer prognosis than other types of breast cancer due to lack of specific, targeted treatment for TNBC.

Thursday, June 14, 2012

The Anne M. Wolf Fund For Triple Negative Breast Cancer Research

Mission

Our mission is to support scientists and researchers in their effort to find a cure and to raise awareness about breast cancer.

Description

The Anne M. Wolf Breast Cancer Foundation is a 501(c)(3) non-profit organization founded in honor of Anne M. Wolf, who was just 29 years old when diagnosed with Stage IV Triple Negative Breast Cancer. Her battle against breast cancer ended after four short months of fighting. During her fight, she was surrounded by an 'army' of family, friends, co-workers, neighbors, and various community members who were determined, like her, to be victorious over breast cancer.

A majority of proceeds will benefit The Ohio State University Comprehensive Cancer Center- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. Funds will be used to support Triple Negative Breast cancer research efforts, under the direction of Dr. Charles Shapiro, MD and Director of Breast and Medical Oncology.

The Anne M. Wolf Breast Cancer Foundation
P.O. Box 83, Orrville, OH 44667
http://www.annesarmy.org

http://giveto.osu.edu/areastosupport/philanthropyprograms/campuscampaign/YourGiftsatWork/Anne.M.Wolf.fund.html (Click to link)